Study reports comparable treatment effects of biosimilars and reference biologics in rheumatoid arthritis
Adalimumab, infliximab, and etanercept biosimilars were found to have clinically equal treatment effects compared to their reference biologics for the treatment of rheumatoid arthritis (RA), …